HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The New Normal? How COVID-19 Has Impacted Europe's Consumer Health Market

Executive Summary

IQVIA Consumer Health's analysis of the impact of the coronavirus pandemic on Europe's OTC market based on the latest sales data. 

You may also be interested in...



2020 In Review: HBW Insight’s Five Key Takeaways For The European OTC Industry

HBW Insight extracts five key lessons from 2020, the year the coronavirus pandemic swept its way across Europe. 

The Bubble Bursts: Germany’s OTC Market Slumps As COVID-19 Impact Deepens

After an almost 50% rise in sales in March, Germany's OTC market suffered a severe contraction in April as the 'boom' effect of the coronavirus wore off, according to data from Sempora Consulting. 

Podcast: COVID-19's Impact On The European Consumer Health Market

As the coronavirus continues to spread across Europe, HBW Insight editors Tom Gallen and David Ridley discuss how the pandemic is impacting the region's consumer healthcare market. 

Related Content

Topics

UsernamePublicRestriction

Register

LL1135866

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel